NCT01561807View on ClinicalTrials.gov

A Study to Investigate VX-787 Given to Adult Volunteers Inoculated With Live Influenza Virus

PHASE2CompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

October 31, 2012

Conditions
Influenza Virus
Interventions
DRUG

VX-787

DRUG

Placebo

Trial Locations (1)

Unknown

London

All Listed Sponsors
lead

Vertex Pharmaceuticals Incorporated

INDUSTRY

NCT01561807 - A Study to Investigate VX-787 Given to Adult Volunteers Inoculated With Live Influenza Virus | Biotech Hunter | Biotech Hunter